You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

allo-HSCT

Showing 51 - 75 of 1,192
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Secondary Acute Myeloid Leukemia Evolving From MDS, Allogeneic Hematopoietic Stem Cell Transplantation, Conditioning Trial in

Recruiting
  • Secondary Acute Myeloid Leukemia Evolving From MDS
  • +2 more
  • Granulocyte Colony-Stimulating Factor(G-CSF)
  • +4 more
  • Guangzhou, Guangdong, China
    Department of Hematology,Nanfang Hospital, Southern Medical Univ
Jul 5, 2022

Myelodysplastic Syndrome, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in Boston (biological, procedure, drug)

Terminated
Has Results
  • Myelodysplastic Syndrome
  • +2 more
  • GVAX
  • +6 more
  • Boston, Massachusetts
  • +3 more
Jun 30, 2022

Hematological Malignancies, Hematopoietic Stem Cell Transplantation Trial in Guangzhou (PBSCs, Cord, BMSCs)

Recruiting
  • Hematological Malignancies
  • Hematopoietic Stem Cell Transplantation
  • PBSCs
  • +2 more
  • Guangzhou, Guangdong, China
    Department of Hematology,Nanfang Hospital, Southern Medical Univ
Mar 13, 2022

Epidermolysis Bullosa Trial in Minneapolis (drug, procedure, radiation)

Active, not recruiting
  • Epidermolysis Bullosa
  • Minneapolis, Minnesota
    University of Minnesota Masonic Cancer Center and Medical Center
Feb 25, 2022

Microbiota Composition With cGVHD After Allo-HSCT

Recruiting
  • Hematopoietic Stem Cell Transplantation
  • +3 more
  • blood sample
  • stool sample
  • Hangzhou, Zhejiang, China
  • +9 more
Jul 31, 2022

Hematological Tumors, Recurrence Trial in Shanghai (Peg interferon alfa-2b)

Recruiting
  • Hematological Neoplasms
  • Recurrence
  • Peg interferon alfa-2b
  • Shanghai, Shanghai, China
    Shanghai Jiao Tong University Affilated First People's Hospital
Oct 10, 2021

Epidermolysis Bullosa Trial in Minneapolis (drug, radiation, procedure, biological)

Recruiting
  • Epidermolysis Bullosa
  • Minneapolis, Minnesota
    University of Minnesota Masonic Cancer Center and Medical Center
Jan 20, 2022

Leukemia, Acute Trial in New York (Allogeneic T cell progenitors, cultured ex-vivo)

Recruiting
  • Leukemia, Acute
  • Allogeneic T cell progenitors, cultured ex-vivo
  • New York, New York
    Memorial Sloan Kettering Cancer Center (MSKCC)
Dec 9, 2021

Acute GVHD in Intestine Trial in Beijing, Jinan (Fecal Microbiota Transplantation, drug)

Recruiting
  • Acute Graft Versus Host Disease in Intestine
  • Fecal Microbiota Transplantation
  • drug
  • Beijing, Beijing, China
  • +1 more
Aug 30, 2021

AML - Acute Myeloid Leukemia, MDS (Myelodysplastic Syndrome), Mixed Phenotype Acute Leukemia Trial in Palo Alto (T-allo10)

Recruiting
  • AML - Acute Myeloid Leukemia
  • +5 more
  • T-allo10
  • Palo Alto, California
    Lucile Packard Children's Hospital
Feb 2, 2022

Novel Drugs After Allo-HSCT in Patients With Multiple Myeloma

Recruiting
  • Multiple Myeloma
  • Stem Cell Transplant
    • Firenze, Italy
    • +1 more
    Aug 19, 2021

    Precursor Cell Lymphoblastic Leukemia-Lymphoma, Philadelphia-Positive Acute Lymphoblastic Leukemia, ALL, Adult Trial in Xi'an

    Recruiting
    • Precursor Cell Lymphoblastic Leukemia-Lymphoma
    • +2 more
    • Xi'an, Shaanxi, China
      First Affiliated Hospital of Xian Jiaotong University
    Sep 29, 2021

    Acute Leukemia, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Minneapolis (HSCT with TBI Regimen, HSCT with

    Recruiting
    • Acute Leukemia
    • +27 more
    • HSCT with TBI Regimen
    • HSCT with Non-TBI Regimen
    • Minneapolis, Minnesota
      Masonic Cancer Center at University of Minnesota
    Apr 12, 2022

    Hematologic Malignancy Trial in Saint Petersburg (Prophylactic Donor lymphocytes infusions, Preventive Donor lymphocytes

    Recruiting
    • Hematologic Malignancy
    • Prophylactic Donor lymphocytes infusions
    • Preventive Donor lymphocytes infusions
    • Saint Petersburg, Russian Federation
      RM Gorbacheva Research Institute
    Aug 16, 2021

    Non-Hodgkin's Lymphoma, B-Cell ALL, B-Cell CLL Trial in Houston (CD19.CAR-CD28Z T Cells - dose escalation 2, CD19.CAR-CD28Z T

    Recruiting
    • Non-Hodgkin's Lymphoma
    • +2 more
    • CD19.CAR-CD28Z T Cells - dose escalation 2
    • CD19.CAR-CD28Z T Cells - dose escalation 1
    • Houston, Texas
    • +1 more
    Feb 10, 2022

    Engraft Failure, Relapse, GVHD Trial (decitabine, Acetylcysteine, Semustine)

    Not yet recruiting
    • Engraft Failure
    • +2 more
    • (no location specified)
    Jun 22, 2021

    Relapse Rate After Allo-HSCT Trial in Shanghai (Flu-Bu-Mel)

    Active, not recruiting
    • Relapse Rate After Allo-HSCT
    • Shanghai, China
    • +1 more
    Jun 1, 2021

    Co-existing Mutations on Sorafenib Maintenance Therapy After

    Completed
    • Acute Myeloid Leukemia
    • +2 more
    • Guangzhou, Guangdong, China
      Department of Hematology,Nanfang Hospital, Southern Medical Univ
    May 30, 2022

    Graft Vs Host Disease Trial in Beijing (UC-MSC, Anti-CD25 mAb)

    Not yet recruiting
    • Graft Vs Host Disease
    • Beijing, Beijing, China
      Peking University Insititute of Hematology, Peking University Pe
    Feb 1, 2021

    Acute Leukemia, Relapse, Hematopoietic Stem Cell Transplantation Trial in Guangzhou (Sorafenib)

    Recruiting
    • Acute Leukemia
    • +2 more
    • Guangzhou, Guangdong, China
      Department of Hematology,Nanfang Hospital, Southern Medical Univ
    Oct 30, 2021

    GVHD, Acute Trial in Shanghai (PT-CY-FK +/-ATG)

    Completed
    • GVHD, Acute
    • PT-CY-FK +/-ATG
    • Shanghai, Shanghai, China
      Rui Jin Hospital
    May 19, 2021

    Lymphoid Tumor Trial in Shanghai (Flu-Bu-Mel-E)

    Recruiting
    • Lymphoid Neoplasm
    • Shanghai, China
      Blood & Marrow Transplantation Center, RuiJin Hospital
    May 22, 2021

    Hematologic Diseases Trial in Palo Alto (biological, device, drug)

    Recruiting
    • Hematologic Diseases
    • Allogeneic Stem Cell Transplant
    • +2 more
    • Palo Alto, California
      Lucile Packard Children's Hospital
    Mar 25, 2022

    GVHD, Acute Trial in Denmark, Norway, Sweden (Decidua Stroma Cells (DSC), Best available Treatment (BAT))

    Recruiting
    • GVHD, Acute
    • Decidua Stroma Cells (DSC)
    • Best available Treatment (BAT)
    • Copenhagen, Denmark
    • +5 more
    Sep 30, 2021

    Donor CHIP and Allogeneic HSCT Outcome

    Recruiting
    • Clonal Hematopoiesis
    • Next generation sequencing
    • Hong Kong, Hong Kong
      The University of Hong Kong
    Dec 29, 2020